Increased performances of the biological diagnosis of the antiphospholipid syndrome by the use of a multiplex assay

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Senant M ^a,b   Rostane, H ^a   Fernani Oukil, F ^a   Hosking, F ^a   Bellery, F ^a   Courchinoux, A ^a   Tartour, E ^a,b   Darnige, L ^a   Dragon Durey, M A ^a,b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; PROTHROMBIN ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER; CARDIOLIPIN;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; AREA UNDER THE CURVE; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS WASTAGE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MULTIPLEX ANTIPHOSPHOLIPID SYNDROME ASSAY; RECEIVER OPERATING CHARACTERISTIC; VEIN THROMBOSIS; ABORTION, SPONTANEOUS; BLOOD; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; ODDS RATIO; PREGNANCY; PRESCHOOL CHILD; REPRODUCIBILITY; THROMBOSIS; VERY ELDERLY; YOUNG ADULT;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; AUTOIMMUNITY; BETA 2-GLYCOPROTEIN I; BIOMARKERS; CARDIOLIPINS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; ODDS RATIO; PREGNANCY; REPRODUCIBILITY OF RESULTS; ROC CURVE; THROMBOSIS; YOUNG ADULT;

EID: 84930001397     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/983094     Document Type: Article

References (19)

1. R. A. Asherson, R. Cervera, P. G. De Groot et al. , "Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines, " Lupus, vol. 12, no. 7, pp. 530-534, 2003.
2. R. Cervera, J.-C. Piette, J. Font et al. , "Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1, 000 patients, " Arthritis and Rheumatism, vol. 46, no. 4, pp. 1019-1027, 2002.
3. S. Miyakis, M. D. Lockshin, T. Atsumi et al. , "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), " Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295-306, 2006.
4. M. Mahler, G. L. Norman, P. L. Meroni, and M. Khamashta, "Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome, " Autoimmunity Reviews, vol. 12, no. 2, pp. 313-317, 2012.
5. S. Cucnik, T. Kveder, I. Krizaj, B. Rozman, and B. Bozic, "High avidity anti-2-glycoprotein I antibodies in patients with antiphospholipid syndrome, " Annals of the Rheumatic Diseases, vol. 63, no. 11, pp. 1478-1482, 2004.
6. M. Sanmarco and N. Bardin, "The contribution of antiphosphatidylethanolamine antibodies in the diagnosis of the antiphospholipid syndrome, " Lupus, vol. 21, no. 7, pp. 727-728, 2012.
7. T. D. Jaskowski, A. R. Wilson, H. R. Hill, W. D. Branch, andA. E. Tebo, "Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome" Clinica Chimica Acta, vol. 410, no. 1-2, pp. 19-24, 2009.
8. M. S. Sater, R. R. Finan, F. M. Abu-Hijleh, T. M. Abu-Hijleh, and W. Y. Almawi, "Anti-phosphatidylserine, anti-cardiolipin, anti-beta2 glycoprotein i and anti-prothrombin antibodies in recurrent miscarriage at 8-12 gestational weeks, " European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 163, no. 2, pp. 170-174, 2012.
9. V. Pengo, G. Denas, E. Bison et al. , "Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA), " Thrombosis Research, vol. 126, no. 2, pp. 150-153, 2010.
10. A. Hoxha, A. Ruffatti, M. Pittoni et al. , "Theclinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome, " Clinica Chimica Acta, vol. 413, no. 9-10, pp. 911-913, 2012.
11. M. Galli, G. Reber, P. de Moerloose, and P. G. de Groot, "Invitation to a debate on the serological criteria that define the antiphospholipid syndrome, " Journal of Thrombosis and Haemostasis, vol. 6, no. 2, pp. 399-401, 2008.
12. S. S. Pierangeli and E. N. Harris, "A quarter of a century in anticardiolipin antibody testing and attempted standardization has led us to here, which is" Seminars in Thrombosis and Hemostasis, vol. 34, no. 4, pp. 313-328, 2008.
13. M. Galli, G. Borrelli, E. M. Jacobsen et al. , "Clinical significance of different antiphospholipid antibodies in theWAPS (warfarin in the antiphospholipid syndrome) study, " Blood, vol. 110, no. 4, pp. 1178-1183, 2007.
14. R. Forastiero, M. Martinuzzo, G. Pombo et al. , "A prospective study of antibodies to 2-glycoprotein I and prothrombin, and risk of thrombosis, " Journal ofThrombosis and Haemostasis, vol. 3, no. 6, pp. 1231-1238, 2005.
15. P. von Landenberg, T. Matthias, J. Zaech et al. , "Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome, " American Journal of Reproductive Immunology, vol. 49, no. 1, pp. 51-56, 2003.
16. J. Nojima, H. Kuratsune, E. Suehisa et al. , "Association between the prevalence of antibodies to 2-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications, " Clinical Chemistry, vol. 47, no. 6, pp. 1008-1015, 2001.
17. M. L. Bertolaccini, T. Atsumi, T. Koike, G. R. V. Hughes, and M. A. Khamashta, "Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus, " Thrombosis and Haemostasis, vol. 93, no. 2, pp. 289-297, 2005.
18. S. Sciascia and M. L. Bertolaccini, "Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome, " Lupus, vol. 23, no. 12, pp. 1309-1312, 2014.
19. K. Otomo, T. Atsumi, O. Amengual et al. , "Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events, " Arthritis and Rheumatism, vol. 64, no. 2, pp. 504-512, 2012.